Can azithromycin be used to treat bacterial tonsillitis and pharyngitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Azithromycin Be Used for Tonsillitis and Pharyngitis?

Azithromycin can be used for bacterial tonsillitis and pharyngitis, but it should only be prescribed as an alternative agent when penicillin or amoxicillin cannot be used, typically in cases of penicillin allergy. 1, 2, 3

First-Line Treatment Remains Penicillin or Amoxicillin

  • Penicillin V or amoxicillin for 10 days is the recommended first-line treatment for Group A beta-hemolytic streptococcal (GABHS) pharyngitis/tonsillitis due to proven efficacy, narrow spectrum, safety profile, low cost, and the absence of any documented penicillin resistance in GABHS worldwide. 1, 4

  • Penicillin V should be dosed at 250 mg twice or three times daily in children and 250 mg four times daily or 500 mg twice daily in adolescents and adults for 10 days. 4

  • Amoxicillin is often preferred in young children at 50 mg/kg once daily (maximum 1000 mg) or 25 mg/kg twice daily (maximum 500 mg per dose) for 10 days due to better taste acceptance, though efficacy is equivalent to penicillin. 1, 4

When Azithromycin Is Appropriate

Azithromycin should be reserved for patients who cannot tolerate first-line beta-lactam therapy, particularly those with penicillin allergy. 2, 3

FDA-Approved Dosing for Pharyngitis/Tonsillitis

  • In children (age 2 years and above): Azithromycin 12 mg/kg once daily for 5 days is the FDA-approved regimen for pharyngitis/tonsillitis caused by Streptococcus pyogenes. 3

  • In adults: The standard regimen from clinical trials was azithromycin 12 mg/kg once daily for 5 days (typically 500 mg daily for adults). 3

Evidence of Efficacy

  • A systematic review found no evidence of differing efficacy between azithromycin and comparator agents (including penicillin) for acute pharyngitis in adults and children. 1

  • In three U.S. double-blind controlled studies, azithromycin (12 mg/kg once daily for 5 days) was clinically and microbiologically statistically superior to penicillin V (250 mg three times daily for 10 days) at Day 14 and Day 30, with bacteriologic eradication rates of 95% vs 73% at Day 14 and 77% vs 63% at Day 30. 3

  • However, meta-analysis data comparing azithromycin dosing regimens in children demonstrates that higher total doses are more effective: 60 mg/kg total course was superior to 10-day comparators, while 30 mg/kg total course was inferior. 5

Critical Dosing Considerations

The 12 mg/kg once daily for 5 days regimen (total 60 mg/kg) is essential for optimal efficacy. Lower doses result in significantly higher failure rates. 5, 6

  • A study comparing two azithromycin dosages found that 20 mg/kg/day for 3 days (total 60 mg/kg) achieved 94.2% bacteriologic eradication compared to only 57.8% with 10 mg/kg/day for 3 days (total 30 mg/kg). 6

  • The 5-day regimen is superior to 3-day regimens in children, even when total dose is equivalent. 5

  • Azithromycin is the only antibiotic that requires only 5 days of therapy (rather than 10 days) due to its unique pharmacokinetic profile with prolonged tissue concentrations. 7

Important Resistance and Safety Considerations

Macrolide Resistance

  • Local macrolide resistance patterns must be considered before prescribing azithromycin, as resistance among GABHS varies geographically and temporally, with approximately 5-8% resistance in the United States. 7, 4, 2

  • Approximately 1% of azithromycin-susceptible S. pyogenes isolates became resistant to azithromycin following therapy in clinical trials. 3

  • One study found that 7.9% of GABHS strains were resistant to azithromycin before treatment. 6

Tolerability Profile

  • Azithromycin has a higher incidence of treatment-related adverse events (primarily gastrointestinal) compared to penicillin: 18% vs 13% in adults and 18-23% vs 3% in children. 3, 6

  • The most common side effects are diarrhea/loose stools (5-11%), vomiting (2-6%), and abdominal pain (1-3%). 3

Critical Pitfalls to Avoid

  • Do not use azithromycin as first-line therapy when penicillin or amoxicillin can be used, as this contributes to antimicrobial resistance and is not guideline-recommended. 2, 3

  • Do not prescribe inadequate doses: The 10 mg/kg/day for 3 days regimen (total 30 mg/kg) has unacceptably high failure rates and should not be used. 5, 6

  • Do not assume azithromycin prevents rheumatic fever: The FDA label explicitly states that "data establishing efficacy of azithromycin in subsequent prevention of rheumatic fever are not available," whereas penicillin by intramuscular route remains the usual drug of choice for prophylaxis. 3

  • Susceptibility testing should be performed when treating with azithromycin due to variable resistance patterns. 3

Alternative Options for Penicillin Allergy

For patients with non-anaphylactic penicillin allergy, first-generation cephalosporins (such as cephalexin 20 mg/kg twice daily for 10 days) are preferred over azithromycin due to superior efficacy and lower resistance concerns. 7, 4

For patients with immediate/anaphylactic penicillin allergy where all beta-lactams must be avoided, clindamycin (7 mg/kg three times daily for 10 days) is preferred over azithromycin in areas with high macrolide resistance. 7, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Azithromycin for Streptococcal Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Antibiotic Treatment for Group A Streptococcal Tonsillitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Higher dosages of azithromycin are more effective in treatment of group A streptococcal tonsillopharyngitis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005

Guideline

Alternative Treatments to Penicillin for Streptococcal Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.